Barclays’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-339
| Closed | -$9K | – | 4065 |
|
|
2021
Q2 | $9K | Buy |
+339
| New | +$9K | ﹤0.01% | 3896 |
|
|
2020
Q3 | – | Sell |
-2,530
| Closed | -$53K | – | 3848 |
|
|
2020
Q2 | $53K | Buy |
+2,530
| New | +$53K | ﹤0.01% | 3380 |
|
|
2020
Q1 | – | Sell |
-2,710
| Closed | -$78K | – | 3832 |
|
|
2019
Q4 | $78K | Buy |
+2,710
| New | +$78K | ﹤0.01% | 3499 |
|
|
2019
Q3 | – | Sell |
-2,797
| Closed | -$221K | – | 4309 |
|
|
2019
Q2 | $221K | Sell |
2,797
-10,262
| -79% | -$811K | ﹤0.01% | 3145 |
|
|
2019
Q1 | $862K | Sell |
13,059
-2,953
| -18% | -$195K | ﹤0.01% | 2255 |
|
|
2018
Q4 | $889K | Buy |
16,012
+15,432
| +2,661% | +$857K | ﹤0.01% | 1896 |
|
|
2018
Q3 | $52K | Sell |
580
-220
| -28% | -$19.7K | ﹤0.01% | 3727 |
|
|
2018
Q2 | $75K | Buy |
+800
| New | +$75K | ﹤0.01% | 3175 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4306 |
|